The Heart Failure, LVAD & Heart Transplant Program, part of California Pacific Medical Center's Heart and Vascular Center, emphasizes total patient care and end-stage cardiac disease management. The goal of this approach is to provide patients with excellent results and the best opportunity for a successful outcome.

Our emphasis on total patient care and cardiac disease management creates a unique program with excellent outcomes and personal attention. Our team works with each patient to determine the most suitable treatment for your condition.

Program Highlights

California Pacific initiated the nation’s first heart transplant service in a private institution in 1984 and has been at the forefront of disease management and transplant ever since. We were also the first center on the West Coast to successfully place and maintain a patient on a bi-ventricular assist device (BiVAD) while waiting for a donor heart and have been a leader in developing “bridge-to-transplantation” therapy.

With heart disease affecting an estimated 58 million people in the U.S. alone, medical researchers continue to pursue better treatment options. To this end, California Pacific is the only center in Northern California to participate in the pivotal trial for the HeartMate® II LVAD.. This device represents an exciting development in heart research, as its size and weight are believed to accommodate a broader patient population. California Pacific has also been designated a Heart Hope Center for Destination Therapy , offering left ventricular assist devices as long-term treatment for patients who are ineligible for a heart transplant.